Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. (2021)
Attributed to:
nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00502-x
PubMed Identifier: 33640037
Publication URI: http://europepmc.org/abstract/MED/33640037
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10280
ISSN: 0140-6736